266 related articles for article (PubMed ID: 31407321)
21. Real-world treatment patterns and patient-reported outcomes in episodic and chronic migraine in Japan: analysis of data from the Adelphi migraine disease specific programme.
Ueda K; Ye W; Lombard L; Kuga A; Kim Y; Cotton S; Jackson J; Treuer T
J Headache Pain; 2019 Jun; 20(1):68. PubMed ID: 31174464
[TBL] [Abstract][Full Text] [Related]
22. Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 study.
Pradalier A; Auray JP; El Hasnaoui A; Alzahouri K; Dartigues JF; Duru G; Henry P; Lantéri-Minet M; Lucas C; Chazot G; Gaudin AF
Pharmacoeconomics; 2004; 22(15):985-99. PubMed ID: 15449963
[TBL] [Abstract][Full Text] [Related]
23. Chronic migraine in the population: burden, diagnosis, and satisfaction with treatment.
Bigal ME; Serrano D; Reed M; Lipton RB
Neurology; 2008 Aug; 71(8):559-66. PubMed ID: 18711108
[TBL] [Abstract][Full Text] [Related]
24. Validating Migraine-Specific Quality of Life Questionnaire v2.1 in episodic and chronic migraine.
Bagley CL; Rendas-Baum R; Maglinte GA; Yang M; Varon SF; Lee J; Kosinski M
Headache; 2012 Mar; 52(3):409-21. PubMed ID: 21929662
[TBL] [Abstract][Full Text] [Related]
25. Chronic Migraine Epidemiology and Outcomes - International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care.
Adams AM; Buse DC; Leroux E; Lanteri-Minet M; Sakai F; Matharu MS; Katsarava Z; Reed ML; Fanning K; Sommer K; Lipton RB
Cephalalgia; 2023 Jun; 43(6):3331024231180611. PubMed ID: 37314231
[TBL] [Abstract][Full Text] [Related]
26. Improving the classification of migraine subtypes: an empirical approach based on factor mixture models in the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Serrano D; Pavlovic JM; Manack AN; Reed ML; Turkel CC; Buse DC
Headache; 2014 May; 54(5):830-49. PubMed ID: 24527745
[TBL] [Abstract][Full Text] [Related]
27. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
28. The International Burden of Migraine Study (IBMS): study design, methodology, and baseline cohort characteristics.
Payne KA; Varon SF; Kawata AK; Yeomans K; Wilcox TK; Manack A; Buse DC; Lipton RB; Goadsby PJ; Blumenfeld AM
Cephalalgia; 2011 Jul; 31(10):1116-30. PubMed ID: 21690175
[TBL] [Abstract][Full Text] [Related]
29. Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study.
Matsumori Y; Ueda K; Komori M; Zagar AJ; Kim Y; Jaffe DH; Takeshima T; Hirata K
Neurol Ther; 2022 Mar; 11(1):205-222. PubMed ID: 34862581
[TBL] [Abstract][Full Text] [Related]
30. Chronic migraine: epidemiology and disease burden.
Manack AN; Buse DC; Lipton RB
Curr Pain Headache Rep; 2011 Feb; 15(1):70-8. PubMed ID: 21063918
[TBL] [Abstract][Full Text] [Related]
31. Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study.
Scher AI; Buse DC; Fanning KM; Kelly AM; Franznick DA; Adams AM; Lipton RB
Neurology; 2017 Aug; 89(5):461-468. PubMed ID: 28679597
[TBL] [Abstract][Full Text] [Related]
32. Examination of unmet treatment needs among persons with episodic migraine: results of the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Buse DC; Serrano D; Holland S; Reed ML
Headache; 2013 Sep; 53(8):1300-11. PubMed ID: 23879870
[TBL] [Abstract][Full Text] [Related]
33. Economic burden of transformed migraine: results from the American Migraine Prevalence and Prevention (AMPP) Study.
Munakata J; Hazard E; Serrano D; Klingman D; Rupnow MF; Tierce J; Reed M; Lipton RB
Headache; 2009 Apr; 49(4):498-508. PubMed ID: 19245386
[TBL] [Abstract][Full Text] [Related]
34. Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine.
Silberstein SD; Lee L; Gandhi K; Fitzgerald T; Bell J; Cohen JM
Headache; 2018 Nov; 58(10):1579-1592. PubMed ID: 30375650
[TBL] [Abstract][Full Text] [Related]
35. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results.
Reed ML; Fanning KM; Serrano D; Buse DC; Lipton RB
Headache; 2015 Jan; 55(1):76-87. PubMed ID: 25250833
[TBL] [Abstract][Full Text] [Related]
36. Episodic and chronic migraine headache: breaking down barriers to optimal treatment and prevention.
Lipton RB; Silberstein SD
Headache; 2015 Mar; 55 Suppl 2():103-22; quiz 123-6. PubMed ID: 25662743
[TBL] [Abstract][Full Text] [Related]
37. Optimized Acute Treatment of Migraine Is Associated With Greater Productivity in People With Migraine: Results From the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study.
Buse DC; Nahas SJ; Stewart WBF; Armand CE; Reed ML; Fanning KM; Manack Adams A; Lipton RB
J Occup Environ Med; 2023 Apr; 65(4):e261-e268. PubMed ID: 36701797
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis, consultation, treatment, and impact of migraine in the US: Results of the OVERCOME (US) study.
Lipton RB; Nicholson RA; Reed ML; Araujo AB; Jaffe DH; Faries DE; Buse DC; Shapiro RE; Ashina S; Cambron-Mellott MJ; Rowland JC; Pearlman EM
Headache; 2022 Feb; 62(2):122-140. PubMed ID: 35076091
[TBL] [Abstract][Full Text] [Related]
39. A Real-World Analysis of Migraine: A Cross-Sectional Study of Disease Burden and Treatment Patterns.
Ford JH; Jackson J; Milligan G; Cotton S; Ahl J; Aurora SK
Headache; 2017 Nov; 57(10):1532-1544. PubMed ID: 28984356
[TBL] [Abstract][Full Text] [Related]
40. Disability, burden, and symptoms related to sensitization in migraine patients associate with headache frequency.
Di Antonio S; Castaldo M; Ponzano M; Bovis F; Torelli P; Finocchi C; Arendt-Nielsen L
Scand J Pain; 2021 Oct; 21(4):766-777. PubMed ID: 34253003
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
